Venrock Adviser, LLC
NEW YORK, NY · CIK 1615982 · 13F filing filed 2025-05-15
SEC-registered investment adviser since 2014 · limited liability company
- Assets managed$4.5bn
- Staff11 · 11 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds7 (1 hedge) · $4.5bn gross assets
- Form ADV · 2026-04-28SEC adviser record
- Legal entityVENROCK ADVISER, LLC (US)
- Kindhedge funds, private equity
- Others nearbyNew York, NY, Palo Alto, CA
As an employer
- Offices in1 country
- Private fundshedge 1, private equity 6
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 11 |
| Palo Alto, CAUnited States |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
$1.2bn
reported value
-19.4% vs Q4 2024
37positions
76.1%in top 10
4 new
4 added
7 reduced
4 sold out
vs Q4 2024
Holdings, Q1 2025
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| APOGEE THERAPEUTICS INC COM | $317.3m27.00% | Unchanged |
| METSERA INC COM | $102.1m8.69% | New |
| OCULAR THERAPEUTIX INC OCUL | $93.5m7.96% | Unchanged |
| ENLIVEN THERAPEUTICS INC ELVN | $79.2m6.74% | Unchanged |
| KALVISTA PHARMACEUTICALS INC KALV | $77.4m6.58% | Added +454.3k |
| VIRIDIAN THERAPEUTICS INC VRDN | $52.3m4.45% | Unchanged |
| PHARVARIS N V PHVS | $48.9m4.16% | Reduced -107.4k |
| SPYRE THERAPEUTICS INC SYRE | $43.3m3.69% | Unchanged |
| ORUKA THERAPEUTICS INC ORKA | $42.6m3.62% | Added +862.8k |
| PRAXIS PRECISION MEDICINES I PRAX | $37.5m3.19% | Unchanged |
| COGENT BIOSCIENCES INC COGT | $34.0m2.90% | Unchanged |
| DIANTHUS THERAPEUTICS INC DNTH | $31.6m2.69% | Unchanged |
| DYNE THERAPEUTICS INC DYN | $22.7m1.93% | Unchanged |
| CIDARA THERAPEUTICS INC CDTX | $22.6m1.93% | Added +285.8k |
| ENGENE HOLDINGS INC COM | $22.6m1.92% | Unchanged |
| ERASCA INC ERAS | $22.2m1.89% | Unchanged |
| ORIC PHARMACEUTICALS INC ORIC | $17.8m1.51% | Reduced -1.2m |
| UPSTREAM BIO INC UPB | $14.0m1.20% | Unchanged |
| ASTRIA THERAPEUTICS INC CATB | $13.1m1.12% | Unchanged |
| CULLINAN THERAPEUTICS INC CGEM | $10.4m0.89% | Unchanged |
| SOLID BIOSCIENCES INC SLDB | $9.2m0.78% | New |
| SAVARA INC SVRA | $9.0m0.77% | New |
| ABIVAX SA ABVX | $8.4m0.72% | Unchanged |
| PERCEPTIVE CAP SOLUTIONS COR FRNM | $7.7m0.66% | Unchanged |
| SURROZEN INC SRZN | $7.4m0.63% | New |
| ZURA BIO LTD ZURA | $6.5m0.55% | Added +3.0m |
| ARTIVA BIOTHERAPEUTICS INC ARTV | $4.8m0.41% | Unchanged |
| TREVI THERAPEUTICS INC TRVI | $3.9m0.33% | Reduced -651.0k |
| APPLIED THERAPEUTICS INC APLT | $2.7m0.23% | Reduced -4.4m |
| 4D MOLECULAR THERAPEUTICS IN FDMT | $2.2m0.19% | Reduced -2.3m |
| CASI PHARMACEUTICALS INC CASIF | $2.1m0.18% | Unchanged |
| TENAX THERAPEUTICS INC TENX | $1.4m0.12% | Unchanged |
| MERSANA THERAPEUTICS INC COM | $1.2m0.10% | Reduced -6.7m |
| CENTURY THERAPEUTICS INC IPSC | $1.2m0.10% | Reduced -1.5m |
| TENAYA THERAPEUTICS INC TNYA | $886.8k0.08% | Unchanged |
| GLYCOMIMETICS INC COM | $630.0k0.05% | Unchanged |
| INSTIL BIO INC TIL | $576.0k0.05% | Unchanged |
Sold out since Q4 2024
| Security | Value then |
|---|---|
| MERUS N V MRUS | $24.9m592.4k shares |
| AQUESTIVE THERAPEUTICS INC AQST | $9.4m2.6m shares |
| TERNS PHARMACEUTICALS INC | $6.0m1.1m shares |
| TAYSHA GENE THERAPIES INC TSHA | $5.6m3.2m shares |